Lung Cancer Surgery Market Size (2021-2031) and Growth
The Lung Cancer Surgery Market is expected to register a CAGR of 4.40% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report presents an analysis based on by equipment (dental chairs, dental lasers, hand pieces, light cure, scaling unit, CAD/CAM systems, dental radiology equipment). The report further provides analysis based on consumables (anchorage appliances, ligatures, brackets, archwires). The global analysis is further broken-down at regional level and major countries. The market size and forecast at global, regional, and country levels for all the key market segments are covered under the scope. The report offers the value in USD for the above analysis and segments. The report provides key statistics on the market status of the key market players and offers market trends and opportunities.
Purpose of the ReportThe report Lung Cancer Surgery Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Lung Cancer Surgery Market Segmentation
Product- Surgical Instruments
- Monitoring And Visualizing Systems
- Thoracotomy
- Minimally Invasive Surgeries
Strategic Insights
Lung Cancer Surgery Market Growth Drivers- Increasing Incidence of Lung Cancer: With the rising number of lung cancer cases all over the world, due to risk factors such as smoking and environmental pollution, there is a greater demand for surgical interventions. An increase in diagnosis is being created, therefore broadening the surgical market mostly as a result of early detection programs and treatment approaches.
- Growing Awareness and Screening Programs: Greater public awareness has served among others to lead to screening programs, an increase in awareness on the persisting risks of lung cancer, and so better screening programs providing patients with the opportunity to get early surgical intervention for lung cancer assisting the growth of the market to treat lung cancer.
- Investment in Research and Development: Research into new types of surgery and technology is being funded more and more, and it is leading to many new developments in the treatment of lung cancer. Clinical trials and research are constantly refining surgical techniques, patient care, and the overall lung cancer surgery market
- Surgical Technique Advancements: Innovations for new minimally invasive surgical procedures, such as robotic-assisted surgeries and video-assisted thoracoscopic surgery (VATS), will help improve patient outcomes by minimizing recovery times. Such improvements enhance the safety and attractiveness of surgeries, and thus promote growth in lung cancer surgery.
- Robotic-Assisted Surgery: There is an increase in the uptake of robotic-assisted surgical systems that improve precision and shorten recovery times for lung cancer patients. Such advanced technologies allow surgeons to perform complex resections with very minimal invasiveness, thus improving patient outcomes and lowering complication rates.
- Personalized Treatment Approaches: There is a major shift towards personalized treatment plans on genetic profiling and tumor characteristics; an emerging trend in the lung cancer surgery market is the tailoring of surgical interventions based on individual patient needs in order to maximize their efficacy and minimize unwanted procedures or approaches in this area of lung cancer care, which enhances patient outcomes and satisfaction.
- Emerging Markets Growth: Cancers therapeutics, in particular lung cancer surgery, may draw their growth in the near future more from Africa, Asia and Latin America. Sectors rapidly growing tend to improve their health care systems and knowledge about lung cancer thereby creating a gap in the market where more radical treatment such as surgery is required thereby allowing these companies to venture into these emerging markets.
- Hardware and Software Development: Precisely the ability to use artificial intelligence (AI) in the arrangement of surgery and the process of decision making in the management of lung cancer patients may improve their results. For this purpose, healthcare systems economy, and clinical outcomes can be achieving through the employment of AI that can study the patients, do complication forecast or analysis of the surgical techniques used.
- Strategic Partnerships Between Biotech Companies: Synthesis of novel therapies as well as surgical approaches with biotechnology companies can boost lung cancer research. Research that focuses on the addition of certain drugs like immunotherapy or targeted therapy, among others, into the surgical procedure for lung patients will likely add revenue to the current market and improve the patient’s wellbeing.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Lung Cancer Surgery Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Lung Cancer Surgery Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Medtronic, KONINKLIJKE PHILIPS N.V., General Electric Company, Abbott, Omron Healthcare, Inc., F. Hoffmann-La Roche Ltd, Natus Medical Incorporated, BD, OmniVision Technologies, Inc are the some of the key market players operating in the lung cancer surgery market
Asia Pacific is estimated to grow at the highest CAGR over the forecast year (2023 - 2031)
The North America region accounts for highest revenue share lung cancer surgery market
The final report will duly include market size and projection estimates for all the segments from 2021 to 2031, along with a revenue share and compound annual growth rate (%) for the regional/country-wise market wherein 2021-2022 are the historic years, 2023 is considered to be the base year, and the forecast will be provided till 2031, along with CAGR (%)
The market is expected to grow at a CAGR of 10.4%
Chronic disease prevalence and aging population is the major factors boosting the lung cancer surgery market growth.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Lung Cancer Surgery Market - By Product
1.3.2 Lung Cancer Surgery Market - By Procedure
1.3.3 Lung Cancer Surgery Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. LUNG CANCER SURGERY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. LUNG CANCER SURGERY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. LUNG CANCER SURGERY MARKET - GLOBAL MARKET ANALYSIS
6.1. LUNG CANCER SURGERY - GLOBAL MARKET OVERVIEW
6.2. LUNG CANCER SURGERY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. LUNG CANCER SURGERY MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. SURGICAL INSTRUMENTS
7.3.1. Overview
7.3.2. Surgical Instruments Market Forecast and Analysis
7.4. MONITORING AND VISUALIZING SYSTEMS
7.4.1. Overview
7.4.2. Monitoring and Visualizing Systems Market Forecast and Analysis
8. LUNG CANCER SURGERY MARKET - REVENUE AND FORECASTS TO 2028 - PROCEDURE
8.1. OVERVIEW
8.2. PROCEDURE MARKET FORECASTS AND ANALYSIS
8.3. THORACOTOMY
8.3.1. Overview
8.3.2. Thoracotomy Market Forecast and Analysis
8.4. MINIMALLY INVASIVE SURGERIES
8.4.1. Overview
8.4.2. Minimally Invasive Surgeries Market Forecast and Analysis
9. LUNG CANCER SURGERY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Lung Cancer Surgery Market Overview
9.1.2 North America Lung Cancer Surgery Market Forecasts and Analysis
9.1.3 North America Lung Cancer Surgery Market Forecasts and Analysis - By Product
9.1.4 North America Lung Cancer Surgery Market Forecasts and Analysis - By Procedure
9.1.5 North America Lung Cancer Surgery Market Forecasts and Analysis - By Countries
9.1.5.1 United States Lung Cancer Surgery Market
9.1.5.1.1 United States Lung Cancer Surgery Market by Product
9.1.5.1.2 United States Lung Cancer Surgery Market by Procedure
9.1.5.2 Canada Lung Cancer Surgery Market
9.1.5.2.1 Canada Lung Cancer Surgery Market by Product
9.1.5.2.2 Canada Lung Cancer Surgery Market by Procedure
9.1.5.3 Mexico Lung Cancer Surgery Market
9.1.5.3.1 Mexico Lung Cancer Surgery Market by Product
9.1.5.3.2 Mexico Lung Cancer Surgery Market by Procedure
9.2. EUROPE
9.2.1 Europe Lung Cancer Surgery Market Overview
9.2.2 Europe Lung Cancer Surgery Market Forecasts and Analysis
9.2.3 Europe Lung Cancer Surgery Market Forecasts and Analysis - By Product
9.2.4 Europe Lung Cancer Surgery Market Forecasts and Analysis - By Procedure
9.2.5 Europe Lung Cancer Surgery Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Lung Cancer Surgery Market
9.2.5.1.1 Germany Lung Cancer Surgery Market by Product
9.2.5.1.2 Germany Lung Cancer Surgery Market by Procedure
9.2.5.2 France Lung Cancer Surgery Market
9.2.5.2.1 France Lung Cancer Surgery Market by Product
9.2.5.2.2 France Lung Cancer Surgery Market by Procedure
9.2.5.3 Italy Lung Cancer Surgery Market
9.2.5.3.1 Italy Lung Cancer Surgery Market by Product
9.2.5.3.2 Italy Lung Cancer Surgery Market by Procedure
9.2.5.4 Spain Lung Cancer Surgery Market
9.2.5.4.1 Spain Lung Cancer Surgery Market by Product
9.2.5.4.2 Spain Lung Cancer Surgery Market by Procedure
9.2.5.5 United Kingdom Lung Cancer Surgery Market
9.2.5.5.1 United Kingdom Lung Cancer Surgery Market by Product
9.2.5.5.2 United Kingdom Lung Cancer Surgery Market by Procedure
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Lung Cancer Surgery Market Overview
9.3.2 Asia-Pacific Lung Cancer Surgery Market Forecasts and Analysis
9.3.3 Asia-Pacific Lung Cancer Surgery Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Lung Cancer Surgery Market Forecasts and Analysis - By Procedure
9.3.5 Asia-Pacific Lung Cancer Surgery Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Lung Cancer Surgery Market
9.3.5.1.1 Australia Lung Cancer Surgery Market by Product
9.3.5.1.2 Australia Lung Cancer Surgery Market by Procedure
9.3.5.2 China Lung Cancer Surgery Market
9.3.5.2.1 China Lung Cancer Surgery Market by Product
9.3.5.2.2 China Lung Cancer Surgery Market by Procedure
9.3.5.3 India Lung Cancer Surgery Market
9.3.5.3.1 India Lung Cancer Surgery Market by Product
9.3.5.3.2 India Lung Cancer Surgery Market by Procedure
9.3.5.4 Japan Lung Cancer Surgery Market
9.3.5.4.1 Japan Lung Cancer Surgery Market by Product
9.3.5.4.2 Japan Lung Cancer Surgery Market by Procedure
9.3.5.5 South Korea Lung Cancer Surgery Market
9.3.5.5.1 South Korea Lung Cancer Surgery Market by Product
9.3.5.5.2 South Korea Lung Cancer Surgery Market by Procedure
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Lung Cancer Surgery Market Overview
9.4.2 Middle East and Africa Lung Cancer Surgery Market Forecasts and Analysis
9.4.3 Middle East and Africa Lung Cancer Surgery Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Lung Cancer Surgery Market Forecasts and Analysis - By Procedure
9.4.5 Middle East and Africa Lung Cancer Surgery Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Lung Cancer Surgery Market
9.4.5.1.1 South Africa Lung Cancer Surgery Market by Product
9.4.5.1.2 South Africa Lung Cancer Surgery Market by Procedure
9.4.5.2 Saudi Arabia Lung Cancer Surgery Market
9.4.5.2.1 Saudi Arabia Lung Cancer Surgery Market by Product
9.4.5.2.2 Saudi Arabia Lung Cancer Surgery Market by Procedure
9.4.5.3 U.A.E Lung Cancer Surgery Market
9.4.5.3.1 U.A.E Lung Cancer Surgery Market by Product
9.4.5.3.2 U.A.E Lung Cancer Surgery Market by Procedure
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Lung Cancer Surgery Market Overview
9.5.2 South and Central America Lung Cancer Surgery Market Forecasts and Analysis
9.5.3 South and Central America Lung Cancer Surgery Market Forecasts and Analysis - By Product
9.5.4 South and Central America Lung Cancer Surgery Market Forecasts and Analysis - By Procedure
9.5.5 South and Central America Lung Cancer Surgery Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Lung Cancer Surgery Market
9.5.5.1.1 Brazil Lung Cancer Surgery Market by Product
9.5.5.1.2 Brazil Lung Cancer Surgery Market by Procedure
9.5.5.2 Argentina Lung Cancer Surgery Market
9.5.5.2.1 Argentina Lung Cancer Surgery Market by Product
9.5.5.2.2 Argentina Lung Cancer Surgery Market by Procedure
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. LUNG CANCER SURGERY MARKET, KEY COMPANY PROFILES
11.1. KARL STORZ SE AND CO. KG
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. OLYMPUS CORPORATION
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ETHICON US, LLC (JOHNSON AND JOHNSON)
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ACCURAY INCORPORATED
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. TELEFLEX INCORPORATED
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ANGIODYNAMICS
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SCANLAN INTERNATIONAL
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. INTUITIVE SURGICAL
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. TROKAMED GMBH
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ACKERMANN INSTRUMENTE GMBH
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. KARL STORZ SE & Co. KG2. Olympus Corporation3. Ethicon Us, LLC (Johnson & Johnson)4. Accuray Incorporated5. Teleflex Incorporated6. AngioDynamics7. Scanlan International8. Intuitive Surgical9. TROKAMED GmbH10. Ackermann Instrumente GmbH
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For